P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas
Authors:
- 24 June 2020
- journal article
- research article
- Published by Springer Nature in Purinergic Signalling
- Vol. 16 (3) , 327-336
Abstract
Gliomas, the most common primary brain cancer, are highly infiltrative and extremely difficult to treat. Despite advancements, current treatment is limited, with patients surviving for a median of 14–15 months post-diagnosis. Previous research has demonstrated the upregulation of a purinergic receptor, P2X7R, in human gliomas. P2X7R is expressed on both glioma cells and microglia within the glioma microenvironment. It is hypothesized that P2X7R contributes to tumour growth and proliferation via immune-mediated mechanisms involving tumour cells and surrounding microglia. We sought to elucidate the role of P2X7R in a human glioblastoma cell line (U251) and on surgically resected human glioma samples. We treated U251 and human glioma cultures for 72 h with P2X7R antagonists, Brilliant Blue G (BBG), oxidized ATP (oATP) and AZ10606120. Cell counting via fluorescence confocal microscopy was conducted to assess tumour proliferation. We observed no significant reductions in tumour cell numbers following P2X7R antagonism with BBG (20 μM) and oATP (250 μM) in both U251 cells and human glioma samples. Interestingly, there was a significant reduction in tumour cell number in both U251 cells (p = 0.0156) and human glioma samples (p = 0.0476) treated with varying concentrations of AZ10606120. When compared with the conventional chemotherapeutic agent, temozolomide, AZ10606120 was also found to more effectively inhibit tumour proliferation in U251 cells (p < 0.0001). Our pilot results demonstrate a potential trophic role of P2X7R where its inhibition by AZ10606120, a potent antagonist, hinders glioma growth directly or through the inactivation of microglia. This sheds new light on P2X7R as a therapeutic target for human gliomas.Keywords
Funding Information
- Brain Foundation (Mastura Monif)
This publication has 37 references indexed in Scilit:
- Expression of P2X7 Receptor IncreasesIn VivoTumor GrowthCancer Research, 2012
- Expression of macrophage inflammatory protein‐1α and monocyte chemoattractant protein‐1 in glioma‐infiltrating microglia: Involvement of ATP and P2X7receptorJournal of Neuroscience Research, 2010
- Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomasNeuro-Oncology, 2010
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant GliomaCA: A Cancer Journal for Clinicians, 2010
- The Pathobiology of Glioma TumorsAnnual Review of Pathology: Mechanisms of Disease, 2010
- The P2X7 Receptor: A Novel Biomarker of Uterine Epithelial CancersCancer Epidemiology, Biomarkers & Prevention, 2006
- The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses1Neuro-Oncology, 2006
- Human melanomas express functional P2X7 receptorsCell and tissue research, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only targetBritish Journal of Pharmacology, 2003